Analysts / Institutional Investor Meet - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, the schedule for the Analyst/Institutional Investor meetings is attached. Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Results Of The Tribunal Convened Meeting (Including E-Voting) Under Regulation 30 And Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 and Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Voting Results (including e-voting), along with the Scrutinizer's Report, of the Tribunal Convened Meeting of the Shareholders of the Company in respect of the Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited and Neuland Health Sciences Private Limited and Neuland Pharma... Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. Results Of Postal Ballot (Including E-Voting) Under Regulation 30 And Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 and Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the voting results of the said Postal Ballot and would like to inform you that the Resolution set forth in the Postal Ballot Notice has been passed by the Members of the Company. Outcome Of Tribunal Convened Meeting Of The Shareholders Of The Company
The Tribunal Convened Meeting of the shareholders of the Company ('TCM') was held on even date at Taj Krishna, Road No.1, Banjara Hills, Hyderabad 500 034. The Company has provided e-voting facility and voting at the venue through Ballot Paper to the members, on the resolution pertaining to the Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited (Transferee Company) and Neuland Health Sciences Private Limited (First... Updates
With reference to the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2017, submitted on May 12, 2017, we would like to state that Walker Chandiok & Co LLP, Statutory Auditors of the Company, have issued audit reports with unmodified opinion on the Financial Statements for the year ended March 31, 2017. We request you to take the above on record. Press Release
Attached herewith copies of the newspaper publication of Audited financial results for the year ended March 31, 2017, published in Financial Express and Andhra Prabha on May 13, 2017 for your reference.